tiprankstipranks
Champions Oncology Inc (CSBR)
NASDAQ:CSBR
US Market
CSBR
Champions Oncology
RESEARCH TOOLSreports
Want to see CSBR full AI Analyst Report?

Champions Oncology (CSBR) Income Statement

141 Followers

Champions Oncology Income Statement

Last quarter (Q3 2026), Champions Oncology's total revenue was $16.56M, a decrease of -2.82% from the same quarter last year. In Q3, Champions Oncology's net income was $-279.00K. See Champions Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Apr 25Apr 24Apr 23Apr 22Apr 21
Total Revenue
$ 56.94M$ 50.16M$ 53.87M$ 49.11M$ 41.04M
Gross Profit
$ 26.91M$ 20.75M$ 24.34M$ 25.48M$ 19.59M
Operating Expenses
$ 22.07M$ 27.68M$ 28.79M$ 24.87M$ 19.23M
Depreciation and Amortization
$ 1.64M$ 1.87M$ 3.20M$ 2.41M$ 1.58M
EBITDA
$ 6.29M$ -5.41M$ -2.07M$ 3.00M$ 2.02M
Operating Income
$ 4.85M$ -6.92M$ -4.45M$ 607.00K$ 366.00K
Other Income/Expenses
$ -220.00K$ -387.00K$ -818.00K$ -24.00K$ 71.00K
Pretax Income
$ 4.63M$ -7.31M$ -5.27M$ 583.00K$ 437.00K
Net Income
$ 4.70M$ -7.28M$ -5.33M$ 548.00K$ 362.00K
Per Share Metrics
Basic EPS
$ 0.34$ -0.54$ -0.39$ 0.04$ 0.03
Diluted EPS
$ 0.33$ -0.54$ -0.39$ 0.04$ 0.02
Weighted Average Shares Outstanding
 13.66M 13.55M 13.54M 13.20M 13.14M
Weighted Average Shares Outstanding (Diluted)
 14.27M 13.55M 13.54M 14.16M 14.57M
Currency in USD

Champions Oncology Earnings and Revenue History